CDER Organizational Development Team To Be Headed By EPA’s Wright
Executive Summary
CDER's Organizational Development & Strategic Planning Team will be headed by Kenneth Wright, who led several organizational changes during his 25-year tenure at the Environmental Protection Agency
You may also be interested in...
FDA Oncology Reviews Could Remain Split After CBER/CDER Reorganization
FDA is understood to be considering the creation of two divisions within the Center for Drug Evaluation & Research to review oncologic products as part of the CBER/CDER reorganization
FDA Commissioner’s Office To Be Re-aligned Further Under Booz Allen Plan
FDA's Office of the Commissioner will be re-aligned further by the end of fiscal year 2003 with the assistance of Booz Allen Hamilton consultants
CDER Deputy Galson Brings Risk Management Experience To FDA Surveillance
FDA Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, has experience in public health risk assessment that will contribute to the center's revamping of its postmarketing surveillance program.